CPRX Operating Cash Flow (Statement)
Catalyst Pharmaceuticals Inc · Operating Cash Flow (Statement)
CPRX Operating Cash Flow (Statement)
Latest reported$208.21Mperiod ending
CPRX Cash from Operations (-$230.52K → $208.21M)
Annual operating cash flow (statement)
High-resolution chart · PNG
CPRX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 208,670,000 | |
| 239,808,000 | |
| 143,600,000 | |
| 116,047,000 | |
| 60,372,000 | |
| 45,034,864 | |
| 34,611,473 | |
| -25,704,406 | |
| -13,742,572 | |
| -17,963,503 | |
| -18,015,221 | |
| -12,941,783 | |
| -9,875,674 | |
| -5,140,366 | |
| -4,985,049 | |
| -3,757,405 | |
| -7,683,189 | |
| -8,260,412 | |
| -4,424,934 | |
| -1,178,532 | |
| -455,360 | |
| -230,520 |